Establishing Minimal Clinically Important Difference (MCID) Estimates Across PROMIS Domains in Patients Undergoing Cervical Spine Surgery for Myelopathy
Study Design: Retrospective, observational study. Objective: To establish minimal clinically important difference (MCID) estimates among common PROMIS questionnaires for patients with cervical myelopathy undergoing discretionary surgical intervention. Summary of Background Data: Patient-reported outcome measures (PROMs) are becoming more common as part of routine clinical care and alternative payment models. Being able to accurately interpret when a score change indicates a clinically meaningful change for patients is critical. While some MCID estimates among spine patients are reported in the literature, MCID estimates for common PROMIS short-forms (SFs) among spine patients with cervical myelopathy requiring surgery are not well defined. Methods: One hundred seventy-eight adult patients were identified who completed the following PROMIS domains preoperatively, at 3 months postoperatively, and at 1 year postoperatively: Pain Intensity SF 3a; Pain Interference SF 4a; Global Health v1.0 - Mental Health; Global Health v1.0 - Physical Health; and Physical Function SF 10a. MCID estimates were determined using the following distribution-based methodologies: 1/3 SD (preoperative scores); 1/2 SD (preoperative scores); 1/3 SD (change in scores); 1/2 SD (change in scores); minimal detectable change (MDC) at 90%; MDC at 95%; and MDC at 99. Results: At 1 year postoperatively, MCID estimates ranged from 2.9 to 17.2, 3.1 to 17.4, 3.3 to 14.5, 2.7 to 14.0, and 2.8 to 13.6 for PROMIS Pain Intensity, Pain Interference, Global Health - Mental Health, Global Health - Physical Health, and Physical Function, respectively. The common 1/2 SD (change in scores between preoperative and 1-year postoperative timepoints) MCID estimates were 4.1, 4.3, 3.7, 3.7, and 3.6 for PROMIS Pain Intensity, Pain Interference, Global Health - Mental Health, Global Health - Physical Health, and Physical Function, respectively. Conclusions: Our findings provide MCID estimate ranges across a variety of calculation methodologies, including the common distribution-based MCID estimate of 1/2 SD, that may be used to assess appreciable clinical changes in patients with cervical myelopathy undergoing discretionary spine surgery.
Authors
- Harold A. Fogel (ORCID: https://orcid.org/0000-0002-6991-6987)
- Bradley T. Hammoor (ORCID: https://orcid.org/0000-0003-3761-9600)
- David Nathan Bernstein (ORCID: https://orcid.org/0000-0002-1784-3288)
- Megan H. Goh (ORCID: https://orcid.org/0009-0002-8278-4656)
- Harry M. Lightsey (ORCID: https://orcid.org/0000-0001-6729-2798)
- Daniel G. Tobert (ORCID: https://orcid.org/0000-0001-6168-0175)
- Ikechukwu C. Amakiri (ORCID: https://orcid.org/0000-0003-0821-4890)
- Stuart H. Hershman (ORCID: https://orcid.org/0000-0002-2371-2591)
- Chierika U. Clements
Institutions
- Harvard University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Clinical Spine Surgery A Spine Publication
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1097/bsd.0000000000002209
- Primary Topic
- Cervical and Thoracic Myelopathy
- Type
- article
- Field-Weighted Citation Impact
- 0.00